CURE241220C135000
- 1.00
- 0.000.00%
Direxion Daily Healthcare Bull 3X Shares Newsroom
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
(LLY) - Analyzing Eli Lilly's Short Interest
Market Whales and Their Recent Bets on ABBV Options
Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick
Why Is Merck Stock Trading Higher On Monday?
S&P 500, Dow Hit Records Right After Open | Live Stock
Abbott Tests New Balloon-Expandable TAVI System for Aortic Stenosis, Launches First Patient Procedures With Investigational TAVI Device
Merck's WINREVAIR Achieves Results in PAH Study, Trial Ends Early on Efficacy
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Merck Recommends Rejection Of TRC Capital's "Mini-Tender" Offer To Purchase Up To 1M Shares Of Common Stock At $96.38 Per Share
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Market Climbs, Bitcoin Close to $100k | Live Stock
This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and Others
AbbVie Analyst Ratings
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Zevra Niemann-Pick Disease Type C Drug Miplyffa Now Available
Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are...